These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 31242460)
21. [Hypermethylation of promoter region of RAS association domain family gene1A in esophageal squamous cell carcinoma and significance thereof]. Cong DG; Wang SF Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2932-4. PubMed ID: 18261310 [TBL] [Abstract][Full Text] [Related]
22. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance. Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230 [TBL] [Abstract][Full Text] [Related]
23. Hypermethylation of the Ras association domain family 1A (RASSF1A) gene in gallbladder cancer. Kee SK; Lee JY; Kim MJ; Lee SM; Jung YW; Kim YJ; Park JY; Bae HI; Hong HS; Yun YK; Kim SG; Kim DS Mol Cells; 2007 Dec; 24(3):364-71. PubMed ID: 18182852 [TBL] [Abstract][Full Text] [Related]
24. VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer. Zong L; Zhou Y; Zhang M; Chen J; Xiang Y Cancer Immunol Immunother; 2020 Jan; 69(1):33-42. PubMed ID: 31781843 [TBL] [Abstract][Full Text] [Related]
25. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681 [TBL] [Abstract][Full Text] [Related]
26. RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis. Peters I; Rehmet K; Wilke N; Kuczyk MA; Hennenlotter J; Eilers T; Machtens S; Jonas U; Serth J Mol Cancer; 2007 Jul; 6():49. PubMed ID: 17634119 [TBL] [Abstract][Full Text] [Related]
27. Decreased expression of RASSF1A tumor suppressor gene is associated with worse prognosis in clear cell renal cell carcinoma. Klacz J; Wierzbicki PM; Wronska A; Rybarczyk A; Stanislawowski M; Slebioda T; Olejniczak A; Matuszewski M; Kmiec Z Int J Oncol; 2016 Jan; 48(1):55-66. PubMed ID: 26648328 [TBL] [Abstract][Full Text] [Related]
28. Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection. Liu ZJ; Huang Y; Wei L; He JY; Liu QY; Yu XQ; Li ZL; Zhang J; Li B; Sun CJ; Liang WB; Sun AM; Qin Y Neoplasma; 2017; 64(5):795-802. PubMed ID: 28592132 [TBL] [Abstract][Full Text] [Related]
29. [Detection of circulating hypermethylated tumor-specific RASSF1A DNA in ovarian cancer patients]. Ma L; Liu FR; Zhang SL Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):785-7. PubMed ID: 16545186 [TBL] [Abstract][Full Text] [Related]
30. Leptin Protein Expression and Promoter Methylation in Ovarian Cancer: A Strong Prognostic Value with Theranostic Promises. Assidi M; Yahya FM; Al-Zahrani MH; Elkhatib R; Zari A; Elaimi A; Al-Maghrabi J; Dallol A; Buhmeida A; Abu-Elmagd M Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884678 [TBL] [Abstract][Full Text] [Related]
31. CpG island promoter hypermethylation of Ras association domain family 1A gene contributes to gastric carcinogenesis. Joo MK; Kim KH; Park JJ; Yoo HS; Choe J; Kim HJ; Lee BJ; Kim JS; Bak YT Mol Med Rep; 2015 Apr; 11(4):3039-46. PubMed ID: 25483734 [TBL] [Abstract][Full Text] [Related]
32. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas. Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125 [TBL] [Abstract][Full Text] [Related]
33. Aberrant promoter methylation of the RASSF1A and APC genes in epithelial ovarian carcinoma development. Bhagat R; Chadaga S; Premalata CS; Ramesh G; Ramesh C; Pallavi VR; Krishnamoorthy L Cell Oncol (Dordr); 2012 Dec; 35(6):473-9. PubMed ID: 23055343 [TBL] [Abstract][Full Text] [Related]
34. [Methylation status of PCDH10 and RASSF1A gene promoters in colorectal cancer]. Li M; Yan DG; Liu JL Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(6):456-9. PubMed ID: 26875923 [TBL] [Abstract][Full Text] [Related]
35. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients. Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472 [TBL] [Abstract][Full Text] [Related]
36. Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients. Ibanez de Caceres I; Battagli C; Esteller M; Herman JG; Dulaimi E; Edelson MI; Bergman C; Ehya H; Eisenberg BL; Cairns P Cancer Res; 2004 Sep; 64(18):6476-81. PubMed ID: 15374957 [TBL] [Abstract][Full Text] [Related]
37. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers. Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310 [TBL] [Abstract][Full Text] [Related]
38. Impact of PD-L1 and T-cell inflamed gene expression profile on survival in advanced ovarian cancer. Høgdall E; Høgdall C; Vo T; Zhou W; Huang L; Marton M; Keefe SM; Busch-Sørensen M; Sørensen SM; Georgsen J; Mejlgaard E; Nedergaard L; Steiniche T Int J Gynecol Cancer; 2020 Jul; 30(7):1034-1042. PubMed ID: 32527769 [TBL] [Abstract][Full Text] [Related]
39. Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma. Pallarés J; Velasco A; Eritja N; Santacana M; Dolcet X; Cuatrecasas M; Palomar-Asenjo V; Catasús L; Prat J; Matias-Guiu X Mod Pathol; 2008 Jun; 21(6):691-9. PubMed ID: 18469797 [TBL] [Abstract][Full Text] [Related]
40. Prognostic relevance of programmed cell death ligand 1 expression in glioblastoma. Lee KS; Lee K; Yun S; Moon S; Park Y; Han JH; Kim CY; Lee HS; Choe G J Neurooncol; 2018 Feb; 136(3):453-461. PubMed ID: 29147863 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]